Almoosa Health Company (TADAWUL:4018)
Saudi Arabia · Delayed Price · Currency is SAR 106.00
+3.40 (3.31%)
Nov 5, 2026, 3:18 PM AST
Almoosa Health Company Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,498 | 1,416 | 1,202 | 978.97 | 816.04 | 701.54 |
Revenue Growth | 14.15% | 17.79% | 22.82% | 19.97% | 16.32% | 11.54% |
Gross Profit Gross Profit Growth | 441.69 | 423.1 | 368.32 | 304.47 | 228.31 | 214.64 |
Operating Income Operating Income Growth | 204.08 | 219.64 | 182.09 | 124.03 | 55.56 | 66.75 |
Net Income Net Income Growth | 163.4 | 236.54 | 49.35 | 98.15 | 51.02 | 62.42 |
Earnings Per Share EPS Growth | 3.69 | 5.36 | 1.41 | 2.80 | 1.46 | 624.20 |
EPS Growth | -15.35% | 279.95% | -49.71% | 92.38% | -99.77% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmacy Pharmacy Growth | 334.49 | 317.89 | 258.24 | 186.71 | 154.59 | 124.31 |
Medical Services Hospital Medical Services Hospital Growth | 954.56 | 917.51 | 825.55 | 735.45 | 661.45 | 577.23 |
Rehabilitation Centre Rehabilitation Centre Growth | 209.18 | 180.89 | 118.54 | 56.82 | - | - |
Total Total Growth | 1,498 | 1,416 | 1,202 | 978.97 | 816.04 | 701.54 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 65.14 | 80.56 | 38.2 | 15.84 | 15.24 | 58.12 |
Total Debt Total Debt Growth | 1,441 | 870.06 | 1,445 | 1,219 | 795.39 | 513.08 |
Net Cash (Debt) Net Cash Growth | -1,376 | -789.51 | -1,407 | -1,203 | -780.15 | -454.96 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -31.06 | -17.88 | -40.19 | -34.37 | -22.29 | -4549.61 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 162.39 | 180.83 | 139.67 | 40.07 | -10.97 | 197.72 |
Capital Expenditures CapEx Growth | -744.45 | -465.1 | -196.32 | -383.19 | -307.18 | -318.47 |
Free Cash Flow Free Cash Flow Growth | -582.06 | -284.27 | -56.66 | -343.12 | -318.15 | -120.76 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.48% | 29.87% | 30.63% | 31.10% | 27.98% | 30.59% |
Operating Margin | 13.62% | 15.51% | 15.14% | 12.67% | 6.81% | 9.52% |
Pretax Margin | 11.52% | 17.00% | 4.81% | 10.40% | 6.81% | 10.25% |
Profit Margin | 10.91% | 16.70% | 4.11% | 10.03% | 6.25% | 8.90% |
FCF Margin | -38.85% | -20.07% | -4.71% | -35.05% | -38.99% | -17.21% |
Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.300 | 1.000 |
Dividend Per Share Growth | 0% | 30.00% | - |
Dividend Yield | 0.94% | 0.74% | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.74 | 32.85 | - | - | - | - |
Forward PE | 20.88 | 27.28 | - | - | - | - |
PS Ratio | 3.13 | 5.49 | - | - | - | - |